The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) in a real-world population: a comparative observational study

MLA

Matilde Tejlbo Frost, et al. “The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) in a Real-World Population: A Comparative Observational Study.” Critical Care, vol. 24, no. 1, Dec. 2020, pp. 1–3. EBSCOhost, https://doi.org/10.1186/s13054-020-03406-3.

APA

Matilde Tejlbo Frost, Espen Jimenez-Solem, Mikkel Zöllner Ankarfeldt, Martin Erik Nyeland, Anne Helms Andreasen, & Tonny Studsgaard Petersen. (2020). The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) in a real-world population: a comparative observational study. Critical Care, 24(1), 1–3. https://doi.org/10.1186/s13054-020-03406-3

Chicago

Matilde Tejlbo Frost, Espen Jimenez-Solem, Mikkel Zöllner Ankarfeldt, Martin Erik Nyeland, Anne Helms Andreasen, and Tonny Studsgaard Petersen. 2020. “The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) in a Real-World Population: A Comparative Observational Study.” Critical Care 24 (1): 1–3. doi:10.1186/s13054-020-03406-3.